NIH-funded research NIH-funded research

Support services for research on dangerous pathogens

Official title: NERBL Core 3: Biocontainment Research Support Services

Funded at Tufts University Boston · NIH-10910227 · Data updated 2026-11-12

This study is all about making it safer and easier for scientists to work with germs that could cause serious illnesses, so they can better protect us from future outbreaks and help improve treatments for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTufts University Boston
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 18, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$409,038
NIH project number5UC7AI180310-02
Project IDNIH-10910227 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include individuals at risk for infections caused by pathogens like Eastern Equine Encephalitis or Francisella tularemia.

Less likely to help

Patients with non-infectious diseases or those not affected by emerging infectious pathogens may not receive any benefit from this research.

What this research studies

This research focuses on enhancing the safety and efficiency of studies related to pathogens that could cause pandemics and other emerging infections. It aims to provide specialized resources and training for researchers working with high-risk biological materials. By optimizing biocontainment facilities and developing standard procedures, the project seeks to support both academic and industry partners in their efforts to combat infectious diseases. Patients may benefit indirectly through improved medical countermeasures and knowledge gained from this research.

Why it matters

Potential benefit: If successful, this research could lead to better preparedness and response strategies for emerging infectious diseases, ultimately improving patient outcomes.

How similar studies have gone: Other research initiatives focused on biocontainment and pathogen response have shown success in enhancing safety and developing effective medical countermeasures.

Where this research is happening

  • Tufts University Boston
    Boston, United States
    Active

Researchers

  • Principal investigator: Telford, Sam R — Tufts University Boston
  • Study coordinator: Telford, Sam R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.